Female sexual dysfunction in urological patients: findings from a major metropolitan area in the USA.
OBJECTIVE
To determine the prevalence of and risk factors for female sexual dysfunction (FSD) in a practice focused mainly on female urology.


METHODS
A modified version of the Female Sexual Function Index (FSFI) was used to assess the prevalence of FSD in 587 patients who completed the questionnaire. Logistic regression was used to identify risk factors.


RESULTS
The prevalence of FSD was 63%; age, menopausal status and usage of selective serotonin reuptake inhibitors were statistically significant risk factors for FSD.


CONCLUSIONS
FSD is highly prevalent in this population of patients and screening female urological patients for FSD should be considered.
Elsamra
Sammy
S
Department of Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Nazmy
Michael
M
Shin
David
D
Fisch
Harry
H
Sawczuk
Ihor
I
Fromer
Debra
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008875:Middle Aged; D012735:Sexual Dysfunction, Physiological / Q000453:epidemiology* / Q000209:etiology; D020018:Sexual Dysfunctions, Psychological / Q000453:epidemiology* / Q000209:etiology; D014481:United States / Q000453:epidemiology; D014570:Urologic Diseases / Q000150:complications / Q000453:epidemiology*; D055815:Young Adult